Immunology/Inflammation
The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-
A3485 IKK-2 inhibitor VIIISummary: IKK-2 inhibitor,potent and selective
-
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe inhibitor
-
A3850 TAK-2427 CitationTarget: Toll-like receptors (TLRs)|NO Donors / Precursors|IL ReceptorsSummary: TLR 4 signaling inhibitor
-
A4210 Bay 11-7821 (BAY 11-7082)1 CitationSummary: IKK/NF-κB/TNFα inhibitor
-
A4217 QNZ (EVP4593)2 CitationSummary: Potent NF-κB inhibitor
-
A3220 BardoxoloneTarget: COX|iNOSSummary: Once-a-day treatment for CKD
-
A3248 BMS345541 hydrochlorideTarget: IKKSummary: IKK inhibitor,highly selective
-
B1587 IMD 03541 CitationSummary: IKKβ inhibitor
-
B1646 ML130 (Nodinitib-1)Target: NOD1Summary: Potent and selective inhibitor of NOD1
-
B1585 SC-514Summary: ATP-competitive IKK-2 inhibitor, orally active